BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26202309)

  • 1. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
    Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
    J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
    Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
    J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
    Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
    Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
    An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
    Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
    Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
    Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Vitamin D3 Deficiency Induces Albuminuria.
    Sonneveld R; Hoenderop JG; Stavenuiter AW; Ferrantelli E; Baltissen MP; Dijkman HB; Florquin S; Rops AL; Wetzels JF; Berden JH; van der Vlag J; Nijenhuis T
    Am J Pathol; 2016 Apr; 186(4):794-804. PubMed ID: 26851346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
    van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
    Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase in glomerular diseases.
    van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
    Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparanase: another renal player controlled by vitamin D.
    Masola V; Zaza G; Onisto M; Gambaro G
    J Pathol; 2016 Jan; 238(1):7-9. PubMed ID: 26387558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
    Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
    EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
    Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
    J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
    van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase Increases Podocyte Survival and Autophagic Flux after Adriamycin-Induced Injury.
    Abu-Tayeh Suleiman H; Said S; Ali Saleh H; Gamliel-Lazarovich A; Haddad E; Minkov I; Zohar Y; Ilan N; Vlodavsky I; Abassi Z; Assady S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
    Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
    Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of heparanase in overt diabetic nephropathy.
    van den Hoven MJ; Rops AL; Bakker MA; Aten J; Rutjes N; Roestenberg P; Goldschmeding R; Zcharia E; Vlodavsky I; van der Vlag J; Berden JH
    Kidney Int; 2006 Dec; 70(12):2100-8. PubMed ID: 17051139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
    Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
    Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
    Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
    An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
    Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
    Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
    Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.